Skip to main content
Equibles

BARCLAYS PLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 312069 LONDON, X0
Back to PMVP Full portfolio

Position in PMVP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,199
+$3,055 QoQ
Shares Held
27,761
+0.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 64 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMVP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. PMVP ranks #289 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in PMVP

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,199 27,761
2026-03-31 $34,144 27,536
2025-12-31 $34,420 27,536
2025-09-30 $38,550 27,536
2025-06-30 $32,008 30,197
2025-03-31 $32,914 30,197
2024-12-31 $45,597 30,197
2024-09-30 $45,068 30,248
2024-06-30 $753,221 464,952
2024-03-31 $839,034 493,550
2023-12-31 $1,603,828 517,364
2023-09-30 $2,892,013 471,012
2023-06-30 $1,504,402 240,320
2023-03-31 $1,220,747 255,922
2022-12-31 $1,412,174 162,319
2022-09-30 $2,307,064 193,871
2022-06-30 $1,749,201 122,751
2022-03-31 $181,321 8,709